Indiana Judge Overturns Law Protecting Women From Dangerous Abortion Pill

State   |   Steven Ertelt   |   Dec 5, 2014   |   1:16PM   |   Indianapolis, IN

An Indiana judge has overturned a pro-life law the state legislature approved to protect women from the dangerous abortion pill.

Yesterday, federal judge, Jane Magnus-Stinson, ruled in Planned Parenthood’s favor, claiming that a 2013-passed state law regarding the definition of abortion facilities is unconstitutional. The ruling claims that the law violates the Equal Protection Clause of the Constitution.

indianaMike Fichter, President and CEO of Indiana Right to Life, released the following statement:

“This ruling favoring Planned Parenthood is disappointing. Unfortunately, it’s not surprising that a judge appointed by the most pro-abortion president in history, Barack Obama, would rule in Planned Parenthood’s favor. Planned Parenthood continues to be the largest abortion business in the nation and in Indiana.

“The fact that Planned Parenthood even disputed this common sense law shows the organization’s willingness to put its bottom line above women’s health and safety. The law is designed to ensure patients experiencing serious complications following a chemical abortion can be cared for properly.

“The silver lining of this ruling is that it shows legislators how the law could be simply reworded in the next legislative session to ensure patient safety is truly met.”

Currently, an abortion facility that performs only chemical-type abortions does not have be licensed or inspected. The law will require chemical abortion facilities to meet the same requirements as surgical abortion facilities in such areas as reporting standards, physician oversight, cleanliness standards and building accessibility.

Click here to sign up for daily pro-life news alerts from

There are also concerns about failed abortions and how they injure women and children — requiring immediate medical attention.

When the abortion is incomplete, facilities needs to be prepared to deal with a woman experiencing uncontrollable bleeding, infection or other potential side effects of the abortion drug. The licensing requirements will establish that chemical abortion facilities maintain an environment appropriate for dealing with these conditions, IRTL says.